These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping. Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753 [TBL] [Abstract][Full Text] [Related]
25. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy. Mandema JW; Kuck MT; Danhof M J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385 [TBL] [Abstract][Full Text] [Related]
26. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam. Yasui N; Kondo T; Otani K; Furukori H; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084 [TBL] [Abstract][Full Text] [Related]
27. Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes. Warrington JS; Poku JW; von Moltke LL; Shader RI; Harmatz JS; Greenblatt DJ J Pharmacol Exp Ther; 2000 Mar; 292(3):1024-31. PubMed ID: 10688619 [TBL] [Abstract][Full Text] [Related]
28. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam. Klein E J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116 [TBL] [Abstract][Full Text] [Related]
29. Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine. Lau CE; Wang Y; Falk JL J Pharmacol Exp Ther; 1997 Jun; 281(3):1013-29. PubMed ID: 9190832 [TBL] [Abstract][Full Text] [Related]
30. Benzodiazepine drug-drug interactions commonly occurring in clinical practice. Abernethy DR; Greenblatt DJ; Ochs HR; Shader RI Curr Med Res Opin; 1984; 8 Suppl 4():80-93. PubMed ID: 6144465 [TBL] [Abstract][Full Text] [Related]
31. Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo. Ring BJ; Patterson BE; Mitchell MI; Vandenbranden M; Gillespie J; Bedding AW; Jewell H; Payne CD; Forgue ST; Eckstein J; Wrighton SA; Phillips DL Clin Pharmacol Ther; 2005 Jan; 77(1):63-75. PubMed ID: 15637532 [TBL] [Abstract][Full Text] [Related]
32. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers. Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776 [TBL] [Abstract][Full Text] [Related]
33. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin. Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579 [TBL] [Abstract][Full Text] [Related]
34. [Interactions between benzodiazepines and opioids]. Megarbane B; Gueye P; Baud F Ann Med Interne (Paris); 2003 Nov; 154 Spec No 2():S64-72. PubMed ID: 14760228 [TBL] [Abstract][Full Text] [Related]
35. Does metronidazole interact with CYP3A substrates by inhibiting their metabolism through this metabolic pathway? Or should other mechanisms be considered? Roedler R; Neuhauser MM; Penzak SR Ann Pharmacother; 2007 Apr; 41(4):653-8. PubMed ID: 17374625 [TBL] [Abstract][Full Text] [Related]
36. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299 [TBL] [Abstract][Full Text] [Related]
37. Update on rifampin drug interactions, III. Strayhorn VA; Baciewicz AM; Self TH Arch Intern Med; 1997 Nov; 157(21):2453-8. PubMed ID: 9385296 [TBL] [Abstract][Full Text] [Related]
38. Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model. Cubitt HE; Yeo KR; Howgate EM; Rostami-Hodjegan A; Barter ZE Xenobiotica; 2011 Aug; 41(8):623-38. PubMed ID: 21434772 [TBL] [Abstract][Full Text] [Related]
39. Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole. Chien JY; Lucksiri A; Ernest CS; Gorski JC; Wrighton SA; Hall SD Drug Metab Dispos; 2006 Jul; 34(7):1208-19. PubMed ID: 16611859 [TBL] [Abstract][Full Text] [Related]